Related Experiment Videos

[Reduced expression of class I MHC antigens in NIH3T3 cells transformed with activated ras oncogenes]

S Matsushima1

  • 1Section of Bacterial Infection, Hokkaido University, Sapporo, Japan.

[Hokkaido Igaku Zasshi] the Hokkaido Journal of Medical Science
|September 1, 1987
PubMed

Insights

Tumor cells with reduced class I antigen expression, caused by activated ras genes, evade immune surveillance. This study shows decreased H-2K and H-2D region products and mRNA levels in ras-transformed NIH3T3 cells, impacting T-cell recognition.

Area of Science:

  • Immunology
  • Molecular Biology
  • Oncology

Context:

  • Tumor cells require class I molecules for CTL-mediated lysis.
  • Altered class I antigen expression can lead to immune escape.
  • The link between oncogenic pathways and class I regulation is unclear.

Purpose:

  • To investigate the relationship between activated ras oncogenes and class I antigen expression.
  • To analyze class I antigen expression in NIH3T3 cells transformed with activated ras genes.

Summary:

  • NIH3T3 cells transformed with activated ras genes showed reduced surface expression of H-2K and H-2D molecules.
  • This reduction was due to fewer antigen molecules, not altered antibody binding affinity.
  • Decreased mRNA levels for class I and beta-2-microglobulin correlated with reduced surface expression.

Impact:

  • Ras-transformed cells were tumorigenic and less sensitive to killer T-cells.
  • Findings suggest a mechanism for tumor immune evasion involving ras oncogenes and class I antigen downregulation.
  • This research provides insights into cancer immune surveillance evasion strategies.

Related Concept Videos